Hestehave, S., Florea, R., Singleton, S., Fedorec, A. J. H., Caxaria, S., Morgan, O. B., Kopp, K. T., Brown, L. A., Heymann, T., Sikandar, S., Hausch, F., Peirson, S. N., Géranton, S. M. (2025). Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2517405122